Protagonist Therapeutics Inc (PTGX) — Working Capital to Net Assets Ratio
Protagonist Therapeutics Inc (PTGX) has a Working Capital to Net Assets ratio of 83.9% as of September 2025. Working capital of $541.48 Million (current assets of $586.42 Million minus current liabilities of $44.94 Million) is measured against net assets of $645.44 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Protagonist Therapeutics Inc (PTGX) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Protagonist Therapeutics Inc Working Capital to Net Assets (2014–2024)
This chart shows how Protagonist Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 83.9%, reflecting working capital of $541.48 Million against net assets of $645.44 Million USD. For the complete balance sheet picture, see Protagonist Therapeutics Inc (PTGX) total assets.
Annual Working Capital to Net Assets for Protagonist Therapeutics Inc (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Protagonist Therapeutics Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Protagonist Therapeutics Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.6% | $544.24 Million | $675.29 Million | $591.64 Million | $47.40 Million | ▼ -18.7 pp |
| 2023 | 99.3% | $334.30 Million | $336.68 Million | $355.58 Million | $21.27 Million | ▲ +1.0 pp |
| 2022 | 98.3% | $211.90 Million | $215.61 Million | $243.08 Million | $31.18 Million | ▼ -0.6 pp |
| 2021 | 98.9% | $296.72 Million | $300.02 Million | $340.74 Million | $44.02 Million | ▲ +0.4 pp |
| 2020 | 98.5% | $275.37 Million | $279.61 Million | $315.61 Million | $40.24 Million | ▼ -39.0 pp |
| 2019 | 137.4% | $109.91 Million | $79.96 Million | $145.31 Million | $35.41 Million | ▲ +38.5 pp |
| 2018 | 99.0% | $111.34 Million | $112.52 Million | $137.50 Million | $26.16 Million | ▲ +9.1 pp |
| 2017 | 89.9% | $108.39 Million | $120.63 Million | $150.95 Million | $42.55 Million | ▲ +2.1 pp |
| 2016 | 87.7% | $76.81 Million | $87.56 Million | $83.24 Million | $6.43 Million | ▼ -27.7 pp |
| 2015 | 115.5% | $11.08 Million | $9.60 Million | $14.21 Million | $3.13 Million | ▲ +7.8 pp |
| 2014 | 107.6% | $8.56 Million | $7.96 Million | $9.91 Million | $1.35 Million | — |